Search

everythinglearnresearchcommunity

for

Search:↓

Epigenetic changes control how adult stem cells work and can lead to diseases like cancer if they go wrong.

Demodicosis is common and often missed, needing more recognition and treatment in skin care.

Methotrexate treats various disorders by inhibiting DNA synthesis, but careful monitoring is needed to avoid toxicity and manage side effects.

Transplant success has improved with better immunosuppressive drugs and donor matching.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

The AUTS2 gene is linked to neurological disorders and may affect human brain development and cognition.

Targeting the skin's endocannabinoid system could help treat skin disorders.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Brg1 is crucial for hair growth and skin repair by maintaining stem cells and promoting regeneration.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Understanding how epigenetic regulation affects stem cells is key to cancer insights and new treatments.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Bimatoprost is safe and improves eyelash growth in healthy kids but not in those with eyelash loss from chemotherapy or alopecia.

Scientists can grow human hair follicle stem cells in a lab without changing their nature, which could help treat hair loss.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Antiviral medication valganciclovir may improve skin and hair in Trichodysplasia Spinulosa patients.

The NUDT15 gene variant causes severe side effects from azathioprine in some Indian patients.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

6-Gingerol from ginger may slow down hair growth by affecting certain enzymes and growth factors.

Septin4 helps kill colon cancer cells by working with the protein BAX.